The antiviral medication remdesivir has played a controversial role in the COVID-19 treatment protocols used by hospitals that many families allege resulted in the death of their loved ones.
Among the drug’s potential side effects is acute kidney failure, which many physicians argue is the source of the same symptom reported by the medical establishment to have been caused by COVID-19.
Dr. Bryan Ardis, CEO of Ardis Labs and host of The Dr. Ardis Show, said he watched his own father-in-law die in a hospital in February 2020 after being taken through the same hard-wired, standard-of-care protocols he would eventually witness playing out in the lives of others.
“It was the most traumatic thing I’d ever experienced in my whole life,” Ardis told The Epoch Times.
Among the multiple problems with his treatment, Ardis said, his father-in-law had been erroneously diagnosed with having the flu and given an antibiotic called vancomycin, which, like remdesivir, is known to cause acute kidney failure.
“Not only did he not have the flu, but the doctor also treated him with a horrifically toxic, last-resort antibiotic that doesn’t treat the flu,” he said.
When he asked the doctor why he had his father-in-law on the antibiotic that was causing his kidneys to fail, Ardis said the doctor told him that it was hospital protocol.
‘It Wasn’t From the Virus’
For Ardis, it became a foreshadowing of what was to come with the listed COVID symptoms in fact being caused by the drugs used to treat COVID, he alleged.
“In March 2020, every medical doctor started saying they had never seen a respiratory virus move from the lungs to attack the kidneys, which then causes acute kidney failure,” Ardis said.
But the kidney failure wasn’t from the virus, Ardis said.
Initially, Ardis said he thought they were using vancomycin because the stories in the news matched his own experience. However, he later found that the antiviral drug remdesivir, which itself is reported to cause acute kidney failure, was being used through emergency-use authorization to treat COVID before it was later approved by the Food and Drug Administration in October 2020.
